Growing community of inventors

Hangzhou, China

Xi-aopeng Mo

Average Co-Inventor Count = 12.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Xi-aopeng MoXiaobo Wang (1 patent)Xi-aopeng MoXiao Xu (1 patent)Xi-aopeng MoJian Wu (1 patent)Xi-aopeng MoLong Mao (1 patent)Xi-aopeng MoJia Liu (1 patent)Xi-aopeng MoKongen Dai (1 patent)Xi-aopeng MoYimei Bao (1 patent)Xi-aopeng MoBojie Weng (1 patent)Xi-aopeng MoYile Chen (1 patent)Xi-aopeng MoYuning Hua (1 patent)Xi-aopeng MoWanhong Xu (1 patent)Xi-aopeng MoXi-aopeng Mo (1 patent)Xiaobo WangXiaobo Wang (81 patents)Xiao XuXiao Xu (56 patents)Jian WuJian Wu (30 patents)Long MaoLong Mao (25 patents)Jia LiuJia Liu (5 patents)Kongen DaiKongen Dai (3 patents)Yimei BaoYimei Bao (3 patents)Bojie WengBojie Weng (3 patents)Yile ChenYile Chen (3 patents)Yuning HuaYuning Hua (3 patents)Wanhong XuWanhong Xu (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Acea Therapeutics, Inc. (1 from 10 patents)

2. Hangzhou Acea Pharmaceutical Research Co., Ltd. (1 from 1 patent)

3. Zhejiang Acea Pharmaceuticals Co., Ltd. (1 from 1 patent)


1 patent:

1. 11498922 - Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamide

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…